Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma

The Oncologist(2022)10.1093/oncolo/oyac088Source: DataRank Database

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Harper L. Wilson ORCID,Elena Gavrila,Arianne Abreu,Ralph B. D’Agostino ORCID,Wei Zhang ORCID

Live enrichment

PubMed:35552454 PMC:PMC9256026 OpenAlex:https://openalex.org/W4226063126

Cancer Center Support

Grant: P30CA012197

NIH

Grant: U01 CA215848

National Institutes of Health

Grant: 2P30CA012197-22

CORE--DNA SYNTHESIS

National Institutes of Health

Grant: 5U01CA215848-04

Model-based Prediction of Redox-Modulated Responses to Cancer Treatments

Comprehensive Cancer Center of Wake Forest University

National Cancer Institute

goldLicense: cc-by

journalhttps://academic.oup.com/oncolo/article-pdf/27/7/e606/44418351/oyac088.pdf

publisherhttps://academic.oup.com/oncolo/article-pdf/27/7/e606/44418351/oyac088.pdf

journalhttps://doi.org/10.1093/oncolo/oyac088

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35552454

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9256026

Fields of Study

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsRNA modifications and cancer03 medical and health sciences0302 clinical medicineBiomarkers, TumorHead and Neck NeoplasmsHumansPrevalencePrognosisSquamous Cell Carcinoma of Head and NeckTumor Suppressor Protein p53

MeSH Terms

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansPrognosisBiomarkers, TumorPrevalenceTumor Suppressor Protein p53

Keywords

MedicineOncologyHead and neck squamous-cell carcinomaInternal medicineHead and neckImmunotherapyBasal cellCarcinomaHead and neck cancerCancerSurgeryHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckBiomarkers, TumorPrevalenceHumansTumor Suppressor Protein p53Letters to the EditorPrognosis

Sustainable Development Goals

SDG 3: 3. Good health